SanBio Co (JP:4592) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
SanBio Co., Ltd. announces conditional and time-limited approval for its ‘AKUUGO Suspension for Intracranial Implantation,’ with stipulations for quality assessment, emergency preparedness, physician training, and post-marketing surveillance. The company outlines steps to meet these conditions, expecting to commence shipments by the first quarter of the fiscal year ending January 31, 2026.
For further insights into JP:4592 stock, check out TipRanks’ Stock Analysis page.
